Dermatology

Almirall and Absci partnership will help deliver life-changing medicines

21-Nov-2023 By Liza Laws

A partnership combining an integrated drug creation platform with a company specializing in dermatological expertise will deliver life-changing medicines to patients.

LEO Pharma and ICON plc collaborate to improve outcomes for dermatology patients

14-Mar-2023 By Liza Laws

A strategic partnership between LEO Pharma and ICON plc, a clinical development company, was announced on March 10.

LEO Pharma a step closer with chronic eczema cream

13-Feb-2023 By Liza Laws

A Danish company has taken a step closer to making available a cream to treat moderate to severe, chronic hand eczema (CHE).

DiMe releases digital health resources for atopic dermatitis endpoint

08-Sep-2022 By Jenni Spinner

The Digital Medicine Society is offering a library of resources to help promote the use of nocturnal scratch as an endpoint for the troubling skin condition.

Janssen initiates psoriasis trial to bridge racial gaps in care

24-Mar-2022 By Jenni Spinner

The pharmaceutical company's clinical study is intended to examine critical gaps in care for people of color living with moderate to severe plaque psoriasis.

Digital Medicine Society brings pharma firms together on new digital endpoint

02-Nov-2021 By Jenni Spinner

The group is collaborating with AbbVie, Janssen, Novartis, Pfizer, and UCB to help advance nocturnal scratch as a digital endpoint for atopic dermatitis.

Mobile technology facilitates decentralized skin and wound trials

30-Sep-2021 By Jenni Spinner

A leader from Swift Medical describes the company’s skin and wound management technology, and how their tech empowers patient capture of vital information.

Swift Medical launches AI-powered platform for skin and wound trials

20-Sep-2021 By Jenni Spinner

Swift Skin and Wound is a digital imaging technology designed to support decentralized clinical trials conducted to evaluate skin and wound treatments.

WuXi Biologics and Almirall partner to develop dermatological treatments

09-Jan-2020 By Vassia Barba

Almirall enters drug discovery agreement with WuXi Biologics, gaining access to the WuXiBody platform to develop antibodies for the treatment of dermatological diseases.

LEO partners for needle-free delivery of biologics

05-Dec-2019 By Ben Hargreaves

LEO and Portal collaborate in the development of needle-free device to allow patient to self-administer dermatology products.

LEO partners to reduce multi-hour dermatology treatments to seconds

11-Apr-2019 By Vassia Barba

LEO and Elektrofi begin development of injectable dermatological drugs to replace infusions, reducing the amount of time required for treatment.

Novartis joins longitudinal study for RWD

04-Mar-2019 By Maggie Lynch

Novartis Pharma AG partners with Target PharmaSolutions to support its global longitudinal observational study designed to generate real-world clinical data.

Innovaderm continues use of Medrio’s EDC for dermatology trials

14-Feb-2019 By Maggie Lynch

Innovaderm inks deal to extend its use of Medrio’s cloud-based EDC technology for early-phase dermatology clinical trials through 2023.

Sun Pharma buys Japanese drugmaker with two manufacturing sites

27-Nov-2018 By Flora Southey

Sun Pharma has announced plans to acquire Pola Pharma for $1m, adding topical drug and injectables manufacturing capabilities to its network in Japan.

Evotec advancing first-in-class therapies via Almirall collab

17-Sep-2018 By Melissa Fassbender

Evotec and Almirall are using a novel approach to disrupt cell signaling to discover and develop first-in-class therapeutics targeting dermatology diseases.

Novartis sheds oral solid generics in $900m Aurobindo deal

10-Sep-2018 By Flora Southey

In Novartis’ latest restructuring move for 2018, the pharma giant announced plans to sell US generic oral solids and dermatology businesses to Aurobindo Pharma US.

JW Pharmaceutical signs $402m dermatology drug deal with LEO Pharma

04-Sep-2018 By Maggie Lynch

LEO Pharma and JW Pharmaceutical have signed a global out-licensing agreement for an atopic dermatitis drug candidate.

LEO Pharma aims to be dermatology market leader, acquires Bayer's dermatology unit

06-Aug-2018 By Maggie Lynch

LEO Pharma acquires Bayer’s prescription dermatology unit in a definitive agreement, in hopes of reaching their goal of being the leading global dermatology company by 2025.

Synteract acquires CRO Cu-Tech, adds dermatology as new center of development

12-Jul-2018 By Melissa Fassbender

Synteract has acquired the dermatology CRO Cu-Tech, opening a fifth center of development as part of its strategy to develop “highly-expert therapeutic areas of focus,” says CCO.